BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26036991)

  • 1. Diagnostic value of Thallium-201 scintigraphy in differentiating malignant bone tumors from benign bone lesions.
    Inai R; Shinya T; Tada A; Sato S; Fujiwara T; Takeda K; Kunisada T; Yanai H; Ozaki T; Kanazawa S
    Ann Nucl Med; 2015 Oct; 29(8):674-81. PubMed ID: 26036991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thallium-201 Uptake of Giant Cell Tumor: One Step Toward the Differential Diagnosis to Atypically Presenting Osteosarcoma.
    Keller S; Inai R; Sato S; Tada A; Adam G; Yamamura J; Kanazawa S
    AJR Am J Roentgenol; 2017 Jan; 208(1):171-179. PubMed ID: 27726429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thallium-201 scintigraphy in bone and soft-tissue tumors: a comparison of dynamic, early and delayed scans.
    Sugawara Y; Kikuchi T; Kajihara M; Semba T; Ochi T; Fujii T; Mochizuki T; Sakayama K; Nakata S
    Ann Nucl Med; 2005 Sep; 19(6):461-8. PubMed ID: 16248382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both a visual and a semiquantitative analysis for differentiating benign from malignant chondrogenic bone tumors using Tc-99m (V) DMSA scintigraphy: a prospective study.
    Shinya T; Sato S; Kunisada T; Inai R; Yanai H; Ozaki T; Kanazawa S
    Nucl Med Commun; 2015 Aug; 36(8):802-7. PubMed ID: 25932541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thallium-201 scintigraphy is an effective diagnostic modality to distinguish malignant from benign soft-tissue tumors.
    Kawakami N; Kunisada T; Sato S; Morimoto Y; Tanaka M; Sasaki T; Sugihara S; Yanai H; Kanazawa S; Ozaki T
    Clin Nucl Med; 2011 Nov; 36(11):982-6. PubMed ID: 21975384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of thallium-201 scintigraphy in bone and soft tissue tumors.
    Goto Y; Ihara K; Kawauchi S; Ohi R; Sasaki K; Kawai S
    J Orthop Sci; 2002; 7(3):304-12. PubMed ID: 12077654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of F-18 FDG PET and 201Tl scintigraphy for detection of primary malignant bone and soft-tissue tumors.
    Yamamoto Y; Kawaguchi Y; Kawase Y; Maeda Y; Nishiyama Y
    Clin Nucl Med; 2011 Apr; 36(4):290-4. PubMed ID: 21368603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical usefulness of thallium-201 chloride in the diagnosis of tumor (II)--An evaluation in bone, soft tissue and mediastinal tumors].
    Tonami N; Itoh K; Yui N; Terui S; Torizuka K
    Kaku Igaku; 1994 Jan; 31(1):63-74. PubMed ID: 8309112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quantitative assessment of 201Tl-SPECT in tumors of bone and soft tissue].
    Matsui R; Komori T; Nakata Y; Doi K; Tabuchi K; Saika Y; Utsunomiya K; Adachi I; Shimizu T; Sueyoshi K; Narabayashi I; Morishita S
    Kaku Igaku; 1999 Apr; 36(3):219-28. PubMed ID: 10358956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of TI-201 and three-phase bone scintigraphy for bone and soft-tissue tumors.
    Nishiyama Y; Yamamoto Y; Toyama Y; Satoh K; Ohkawa M; Tanabe M
    Clin Nucl Med; 2000 Mar; 25(3):200-5. PubMed ID: 10698418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical usefulness of 201Tl-chloride scintigraphy for the evaluation of metastatic bone lesions].
    Fukui A; Kawamura M; Kataoka M; Fujii T; Yamamoto K; Yoshioka S; Ikezoe J
    Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Jan; 58(1):25-33. PubMed ID: 9493430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of thallium-201 scintigraphy in bone and soft tissue tumors.
    Sato O; Kawai A; Ozaki T; Kunisada T; Danura T; Inoue H
    J Orthop Sci; 1998; 3(6):297-303. PubMed ID: 9811980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of final tumor response to preoperative chemotherapy by Tc-99m MIBI imaging at the middle of chemotherapy in malignant bone and soft tissue tumors: comparison with Tl-201 imaging.
    Taki J; Higuchi T; Sumiya H; Tsuchiya H; Minato H; Tomita K; Tonami N
    J Orthop Res; 2008 Mar; 26(3):411-8. PubMed ID: 17960652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine 201Tl scintigraphy in the follow-up of patients with differentiated thyroid carcinoma: diagnostic accuracy and clinical impact.
    Hsu CC; Chen YW; Huang YF; Chuang YW
    Nucl Med Commun; 2007 Sep; 28(9):681-7. PubMed ID: 17667746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thallium-201 chloride scintigraphy in soft tissue tumors.
    Otsuka H; Terazawa K; Morita N; Otomi Y; Takao S; Iwamoto S; Osaki K; Harada M; Nishitani H
    J Med Invest; 2009 Aug; 56(3-4):136-41. PubMed ID: 19763026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiating benign from malignant bone tumors using fluid-fluid level features on magnetic resonance imaging.
    Yu H; Cui JL; Cui SJ; Sun YC; Cui FZ
    Korean J Radiol; 2014; 15(6):757-63. PubMed ID: 25469087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intense 201 Tl uptake in giant-cell tumour of bone.
    Higuchi T; Taki J; Sumiya H; Kinuya S; Bunko H; Nonomura A; Tsuchiya H; Tonami N
    Nucl Med Commun; 2002 Jun; 23(6):595-9. PubMed ID: 12029217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Will thallium-201 replace gallium-67 in salivary gland scintigraphy?
    Arbab AS; Koizumi K; Hiraike S; Toyama K; Arai T; Araki T
    J Nucl Med; 1996 Nov; 37(11):1819-23. PubMed ID: 8917182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The usefulness of serum thyroglobulin levels and Tl-201 scintigraphy in differentiating between benign and malignant thyroid follicular lesions.
    Tamizu A; Okumura Y; Sato S; Takeda Y; Maki K; Hiraki T; Akaki S; Kuroda M; Kanazawa S; Hiraki Y
    Ann Nucl Med; 2002 Apr; 16(2):95-101. PubMed ID: 12043914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical usefulness of 201Tl-chloride scintigraphy for the diagnosis of bone metastases].
    Koyama M
    Kaku Igaku; 1995 Jan; 32(1):9-18. PubMed ID: 7897873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.